CONTENTS:
- Religious social integration, psychedelics, and psychological distress. Vina S.M., p. 95-106.
- The effect of psilocybe cubensis on spatial memory and BDNF expression in male rats exposed to chronic unpredictable mild stress. Ghaffarzadegan R., Karimi M., Hedayatjoo B., Behnoud H., Jasemi E., Mohammadi M., et al., p. 107-119.
- Preferences, perceptions, and environmental considerations of natural and synthetic psychedelic substances: Findings from the global psychedelic survey. Syed O.A., Petranker R., Fewster E.C., Sobolenko V., Beidas Z., Husain M.I., et al., p. 120-130.
- Unveiling psychedelics: One of the most meaningful events in life associated with improved well-being in Swedish users. Kajonius P.J., Sjöström D., Claesdotter-Knutsson E., p. 131-137.
- Factors associated with psychosis in 2098 methamphetamine users admitted to 104 outpatient counseling centers in 80 cities in Turkey. Guliyev C., Aldemir E., Simsek M., Ögel K., p. 138-146.
- Highs and lows: A mixed-methods analysis of the impact of adult use legalization on medical cannabis patients. Boehnke K.F., Kruger D.J., Cuttler C., Doucette M.L., Wilson-Poe A.R., p. 147-156.
- Identification of cannabis product characteristics and pricing on dark web markets. Nali M.C., Li Z., Purushothaman V., Larsen M.Z., Cuomo R.E., Yang J.S., et al., p. 157-165.
- 24-hour induction of transdermal buprenorphine to buprenorphine extended-release. Azar P., Li V.W., Wong J.S.H., Nikoo M., Machado J., Ignaszewski M.J., et al., p. 166-170.
- Efficacy of screening and brief intervention for alcohol misuse in opioid agonist maintenance treatment: A randomized clinical trial. Gupta S., Pillai R.R., Ghosh A., p. 171-181.
- Prescription and non-prescription anxiolytic use is linked to personal characteristics among university students. Rodriguez-Ruiz J., Miller B.L., Espejo-Siles R., Marin-Lopez I., p. 182-188.